Global Financial Private Capital’s Idexx Laboratories IDXX Stock Holding History

Global Financial Private Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$84K	Sell	253 -104	-29%	-$30.1K	0.01%	250
2020 Q1	$86K	Sell	357 -236	-40%	-$61.6K	0.01%	249
2019 Q4	$155K	Buy	593 +53	+10%	+$14K	0.01%	254
2019 Q3	$147K	Sell	540 -22	-4%	-$6.12K	0.01%	255
2019 Q2	$155K	Buy	+562	New	+$138K	0.01%	278
2018 Q4	–	Sell	-886	Closed	-$221K	–	411
2018 Q3	$221K	Buy	+886	New	+$215K	0.01%	491

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Global Financial Private Capital's IDXX Position: Q2 2020 in Review

Global Financial Private Capital reduced its Idexx Laboratories (IDXX) stake by 29% in Q2 2020, selling an estimated $30.1K and leaving 253 shares worth $84K. The position accounts for 0.01% of the portfolio, ranked #250.

Global Financial Private Capital first reported a position in IDXX in Q3 2018 and has held it in 6 quarters since. The position peaked at $221K in Q3 2018. 802 funds tracked by Wall St. Rank hold IDXX as of Q2 2020.

Global Financial Private Capital held 253 shares of Idexx Laboratories worth $84K as of Q2 2020.
Global Financial Private Capital sold 104 Idexx Laboratories shares in Q2 2020, an estimated $30.1K.
Idexx Laboratories made up 0.01% of Global Financial Private Capital's portfolio in Q2 2020, its #250 holding.
Global Financial Private Capital first reported a position in Idexx Laboratories in Q3 2018 and has held it in 6 quarters since.
Global Financial Private Capital's Idexx Laboratories position peaked at $221K in Q3 2018.
802 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2020.

Based on Global Financial Private Capital's 13F filing for Q2 2020, filed 11 Aug 2020.